Clinical Trials for Leukemia

Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

NCT ID: NCT03826992

This clinical trial is studying a new treatment approach that combines two drugs, venetoclax and Vyxeos (CPX-351), for young patients with acute leukemia that has either returned after previous tre...

Early Ageing During Therapy in AYA Cancer Patients

NCT ID: NCT05062707

This clinical trial, titled "Early Ageing During Therapy in AYA Cancer Patients," is studying how cancer treatments affect young adults aged 18 to 39. The researchers want to understand if these tr...

MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing

NCT ID: NCT05794880

This clinical trial is looking at a new approach to help patients with certain blood cancers, like acute myeloid leukemia and lymphomas, who are in remission. The study focuses on how well a specia...

Peer Support Group for Adolescent and Young Adult (AYA) Allogeneic Stem Cell Transplant Recipients

NCT ID: NCT06704243

This clinical trial is studying a peer support program designed for young adults aged 18 to 39 who have undergone an allogeneic stem cell transplant (which is a type of treatment for certain cancer...

Methadone as an Alternative Treatment for Children Underdoing HSCT

NCT ID: NCT06940570

This clinical trial is studying whether adding methadone, a type of pain medication, can help reduce pain in children aged 6 to 18 who are undergoing stem cell transplants for conditions like leuke...

Study of the Impact of Frequency of Changing PICCline Dressings in Patients With Acute Leukemia

NCT ID: NCT05793801

This clinical trial is studying how often the dressings on a special type of catheter, called a PICCline, should be changed for patients with acute leukemia who are receiving chemotherapy. The rese...

Breath Analysis for the Detection of Invasive Fungal Infections

NCT ID: NCT06537726

This clinical trial is studying a new way to detect invasive fungal infections (IFI) in patients with leukemia who are undergoing chemotherapy. These patients often have low levels of white blood c...

Integrated Actionable Aging Assessment for Cancer Patients Pilot

NCT ID: NCT05871008

This clinical trial, called the Integrated Actionable Aging Assessment for Cancer Patients Pilot (IA3-CP), is focused on improving care for older adults with various types of cancer, including brea...

Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)

NCT ID: NCT05536349

This clinical trial is studying a combination of three medications—pirtobrutinib, venetoclax, and obinutuzumab—to see if they are safe and effective for patients with chronic lymphocytic leukemia (...

Revumenib in Combination With 7+3 + Midostaurin in AML

NCT ID: NCT06313437

This clinical trial is studying a new treatment approach for adults with a type of blood cancer called Acute Myeloid Leukemia (AML), specifically those with certain genetic mutations (NPM1 and FLT3...

A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

NCT ID: NCT04547049

This clinical trial is studying the effectiveness of a specific type of stem cell transplant called haploidentical hematopoietic stem cell transplantation (HSCT) for patients with blood cancers lik...

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

NCT ID: NCT06839456

This clinical trial is studying a new approach to help prevent serious infections in patients with certain types of blood cancers, such as leukemia and lymphoma, after they receive a stem cell tran...

Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia

NCT ID: NCT06890494

This clinical trial is studying a new treatment called BiTE-EV for adults with relapsed or refractory acute B-cell leukemia, which means their cancer has returned or is not responding to other trea...

Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia

NCT ID: NCT05645718

This clinical trial is investigating a new treatment approach for young patients with relapsed B-cell acute lymphoblastic leukemia (B-ALL), a type of blood cancer. The study is testing a combinatio...

SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

NCT ID: NCT04977024

This clinical trial is studying a new vaccine called GEO-CM04S1 to see how well it helps people with blood cancers, like leukemia and lymphoma, build immunity against COVID-19. The trial compares t...

Impact of an Early Warning System on the Prognosis of Patients with Hematological Malignancies Receiving Intensive Chemotherapy with or Without Hematopoietic Cell Transplantation.

NCT ID: NCT06409767

This clinical trial is studying how an early warning system can help improve the health outcomes of patients with blood cancers, such as leukemia, lymphoma, and multiple myeloma, who are receiving ...

A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes

NCT ID: NCT06229912

This clinical trial is studying a new medication called revumenib (also known as SNDX-5613) to see if it can help control certain types of leukemia that have high levels of HOX genes. Researchers a...

YASU Research Registry: for Young Adults with Cancer

NCT ID: NCT06275854

Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL

NCT ID: NCT00881920

The CHARKALL clinical trial is studying a new treatment for patients with certain types of cancer, specifically non-Hodgkin lymphoma, multiple myeloma, or chronic lymphocytic leukemia, that have ei...

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

NCT ID: NCT05745285

This clinical trial is studying how the services and programs offered by the Leukemia and Lymphoma Society (LLS) affect patients with blood cancers like leukemia, lymphoma, and myeloma. The goal is...